I absolutely agree with you on all counts. We spoke with lawyers who do public company securities law and they assured us the soft plans were accepted by the SEC. Makes no sense to me.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr